We are live on ! Find out more
LVAC

LAVA Medtech Acquisition Corp. Class A Common Stock
LVAC

Delisted

LVAC was delisted on the 10th of May, 2023.

Back to rankings

47 hedge funds and large institutions have $93.7M invested in LAVA Medtech Acquisition Corp. Class A Common Stock in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 2

21% more funds holding

Funds holding: 39 → 47 (+8)

8% more capital invested

Capital invested by funds: $86.6M → $93.7M (+$7.11M)

0% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 6

Holders
47
Holders Change
+8
Holders Change %
+20.51%
% of All Funds
0.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
6
Reduced
6
Closed
2
Calls
$199K
Puts
–
Net Calls
+$199K
Net Calls Change
-$1K

Top Buyers

Rank Fund Capital Flow
1
SCM
Saba Capital Management
New York
+$4.99M
2
JP Morgan Chase
JP Morgan Chase
New York
+$3.99M
3
MP
Mangrove Partners
Connecticut
+$3.99M
4
UOC
UBS O'Connor
Illinois
+$3.15M
5
Millennium Management
Millennium Management
New York
+$1.55M

Top Sellers

Rank Fund Capital Flow
1
BCM
Beryl Capital Management
California
-$9.94M
2
CCM
Context Capital Management
California
-$2.25M
3
WAM
Wolverine Asset Management
Illinois
-$29.1K
4
FTCM
Fir Tree Capital Management
New York
-$4.99K
5
Walleye Capital
Walleye Capital
New York
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Saba Capital Management
New York
$10.7M +$4.99M +500,000 +87%
PAMP
2
Polar Asset Management Partners
Ontario, Canada
$7.45M – – –
GL
3
Governors Lane
New York
$4.88M – – –
SC
4
Sculptor Capital
New York
$4.3M +$999 +100 +0%
PC
5
Periscope Capital
Ontario, Canada
$4M -$999 -100 -0%
JP Morgan Chase
6
JP Morgan Chase
New York
$3.98M +$3.99M +400,000 New
MP
7
Mangrove Partners
Connecticut
$3.98M +$3.99M +400,000 New
PMAM
8
Picton Mahoney Asset Management
Ontario, Canada
$3.74M – – –
Balyasny Asset Management
9
Balyasny Asset Management
Illinois
$3.73M – – –
SCM
10
Shaolin Capital Management
Florida
$3.49M – – –
UOC
11
UBS O'Connor
Illinois
$3.14M +$3.15M +315,014 New
Toronto Dominion Bank
12
Toronto Dominion Bank
Ontario, Canada
$2.99M – – –
CSS
13
Cubist Systematic Strategies
Connecticut
$2.67M +$110K +11,023 +4%
Goldman Sachs
14
Goldman Sachs
New York
$2.56M – – –
LA
15
Linden Advisors
New York
$2.49M – – –
TCM
16
Tenor Capital Management
New York
$2.49M – – –
BCM
17
Basso Capital Management
Connecticut
$2.29M +$300K +30,020 +15%
WAM
18
Wolverine Asset Management
Illinois
$2.27M -$29.1K -2,915 -1%
WRBC
19
W.R. Berkley Corp
Connecticut
$2.07M – – –
CH
20
CVI Holdings
Delaware
$2M – – –
AIMCA
21
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$1.99M – – –
D.E. Shaw & Co
22
D.E. Shaw & Co
New York
$1.99M – – –
WCMNY
23
Westchester Capital Management (New York)
New York
$1.99M – – –
Millennium Management
24
Millennium Management
New York
$1.54M +$1.55M +155,000 New
AA
25
AQR Arbitrage
Connecticut
$1.51M – – –
1
2

LVAC Hedge Fund Activity: Q2 2022 in Review

47 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) for Q2 2022, worth a combined $93.7M — up 8.2% from $86.6M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new LVAC positions and 2 closed out — a net gain of 8 holders — while 6 added to existing stakes and 6 trimmed.

The largest buyer was Saba Capital Management, adding an estimated $4.99M. The largest seller was Beryl Capital Management, exiting entirely with an estimated $9.94M sold.

  • 47 institutional investors held LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) as of Q2 2022, up from 39 in Q1 2022.
  • Funds reported $93.7M of LAVA Medtech Acquisition Corp. Class A Common Stock stock for Q2 2022, up 8.2% quarter-over-quarter.
  • 10 funds opened new LAVA Medtech Acquisition Corp. Class A Common Stock positions in Q2 2022 and 2 closed out, a net change of +8 holders.
  • The largest LAVA Medtech Acquisition Corp. Class A Common Stock buyer in Q2 2022 was Saba Capital Management, an estimated $4.99M added.
  • The largest LAVA Medtech Acquisition Corp. Class A Common Stock seller in Q2 2022 was Beryl Capital Management, an estimated $9.94M sold.

Based on aggregated 13F filings for Q2 2022.